💡 @WHO has updated its malaria guidelines to include Coartem® Baby, the first antimalarial specifically developed for newborns and young infants weighing 2-5 kg.

Clinical research co-funded by #EDCTP helped provide key evidence for its use.

🔗 mmv.org/news-resources-search/who-guidelines-malaria-now-include-coartemr-baby-newborns-and-young-infants